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Abstract: Network-based computational approaches to predict unknown genes associated with 
certain diseases are of considerable significance for uncovering the molecular basis of human 
diseases. In this paper, we proposed a kind of new disease-gene-prediction methods by 
combining the path-based similarity with the community structure in the human protein-protein 
interaction network. Firstly, we introduced a set of path-based similarity indices, a novel 
community-based similarity index, and a new similarity combining the path-based similarity 
index. Then we assessed the statistical significance of the measures in distinguishing the disease 
genes from non-disease genes, to confirm their availability in predicting disease genes. Finally, 
we applied these measures to the disease-gene prediction of single disease-gene family, and 
analyzed the performance of these measures in disease-gene prediction, especially the effect of 
the community structure on the prediction performance in detail. The results indicated that 
genes associated with the same or similar diseases commonly reside in the same community of 
the protein-protein interaction network, and the community structure is greatly helpful for the 
disease-gene prediction. 
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1. Introduction 
Identification of the hereditary disease-genes from human genome is one of the most important tasks 
in bioinformatics research[1, 2]. The traditional methods such as the positional cloning via linkage 
analysis were applied to discover the disease-related genes[3, 4], but they encounter difficulties, such as 
the variable disease penetrance [5]
 
and the large number of genes among large family datasets that need to 
be analyzed[6, 7]. The former is an inherent problem that directly limits the performance of these 
traditional methods, while the latter is a labor-intensive task, which will cost much man power and 
resources. Therefore, it is necessary to develop the efficient computational approaches to predict unknown 
genes associated with certain diseases before the experimental research[8, 9]. 
Up to now, many features and resources have been employed to predict disease-related genes, such 
as sequence features[10], gene functional annotations[11, 12],
 
and protein-protein interaction (PPI) 
network[13, 14],
 
etc. Among them, the coverage of the gene functional annotations is limited, though they 
play an important role in disease candidate gene prioritization. In the past decades, benefit from the rapid 
development of experimental technologies (e.g., yeast two-hybrid technology[15]), more and more PPI 
data are becoming available, which greatly promoted the study of the disease-gene discovery[16]. Various 
candidate gene prioritization methods have been proposed based on the PPI network analysis[12, 13, 
17-20]. The theoretical basis of these network-based approaches is that genes associated with the same or 
similar disease phenotype, are not distributed randomly in the network, and they possess many common 
topological features, for example, they usually have high connectivity, reside in more central location of 
the PPI network and cluster together[21-23].  
Based on these topological properties, many scoring systems that match automatically these 
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topological features have been developed[24-29], for example, Xu and Li developed a classifier to predict 
disease genes by combining five different topological features[29]. A long-held and partially proved 
assumption shared by biologists is that genes associated with the same or similar diseases phenotypes are 
likely to be functionally related, and thus they commonly reside in the same neighborhood of molecular 
networks. For example, method based on direct neighbors of disease genes was very simple, but not the 
most efficient in disease-gene prediction[30]; then, Hsu et al considered the indirect neighbors on the 
basis of the direct neighbors of disease genes[31]; while Zhu et al proposed a kind of method integrating 
the direct neighbors, the indirect neighbors and the shortest path length between candidate and known 
disease genes[32]. It is worth noting that module structure is one of important properties in the PPI 
networks[33], while, in the previous studies, little attention was focused on the module property of the 
disease genes. It was clear that, proteins play their functions in a modular fashion, and mutations of 
proteins in the same module may lead to similar disease phenotypes[34]. The modular feature in the PPI 
network can be properly characterized by the community structure in network theory[35, 36].
 
Therefore, 
the community structure should be a more direct and robust property to capture a functional modularity in 
the PPI network. Further, it is expected that genes associated with the same or similar disease phenotypes 
commonly reside in the same community of the PPI network, and the community structure might be 
greatly helpful for disease-gene prediction. 
In this paper, based on the PPI network, we firstly introduce a set of path-based similarity indices 
and a novel community-based similarity index, and then a new similarity combining the path-based 
similarity with community-based similarity is designed. Secondly, we assess the statistical significance of 
the measures in distinguishing the disease genes from non-disease genes, to confirm their availability in 
predicting disease genes. Finally, we apply these measures to the disease-gene prediction of single 
disease-gene family, and analyze the performance of these measures in disease-gene prediction, especially 
the effect of the community structure on the prediction performance in detail.  
2. Datasets 
2.1. Human PPI Datasets 
Protein-protein interaction databases have become a major resource for investigating biological 
networks and pathways in cells. A number of publicly repositories for human PPI are currently available. 
Each of these databases has their own unique features with a large variation in the type and depth of their 
annotations. In this paper, human PPI data is taken from the Human Protein Reference Database 
(HPRD)[37]. All the information in HPRD has been manually extracted from the literatures by expert 
biologists who read, interpret and analyze the published data. We have downloaded a newest version 
(version number: Release 9) of the PPI data, in which the total number of genes annotated with at least 
one interaction is 9465 and the number of binary non-redundant human PPI is 37039. By analyzing the 
human PPI network, we revealed that the PPI network is composed of 110 connected components. The 
largest component contains 9219 proteins and 36900 interactions, while the other 246 proteins are 
distributed into 109 small components with 2-5 proteins. Since the majority of the small sub-networks 
contain only a few genes, it might not be of interest to check the distribution of the disease genes. 
2.2. Disease-Gene Data 
In order to evaluate the performance of our methods, a certain amount of known disease genes are 
required. In present paper, we employ HepatoCellular Carcinoma (HCC) genes that are extracted from 
OncoDB.HCC[38].
 
This data contains 605 significant genes that are concluded to be related to 
hepatocellular carcinoma by three criteria: 
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(1) Based on up-/down-regulated expression, genes were selected with at least three independent 
HCC microarray reports;  
(2) Based on at least 2-fold expression changes within 70% patients, genes were selected with 
re-analyzed Stanford HCC microarray data;  
(3) Genes were selected with web-lab experiments data.  
Among the 605 disease genes, only 448 genes is distributed in the largest component of the present PPI 
network, and thus will be used for further analysis.  
Both the basic topological features of the PPI network and the statistical properties of disease genes 
[39-41] in the main component of PPI network are summarized in Table 1. One can find that the 
disease-genes have higher connectivity, higher network efficiency and shorter distance than those of the 
non-disease genes. In addition, according to the Pearson correlation coefficient of degrees,
 
disease genes 
exhibit an assortative mixing pattern of degrees, while the non-disease genes are disassortative mixing. 
This indicates that the disease genes tend to connect to other disease genes with similar degrees, while the 
non-disease genes with high degrees tend to connect to other non-disease genes with low degrees. From 
the difference of the degree heterogeneity, one can find that the degrees of the non-disease genes are more 
dispersive than those of the disease genes. 
 
Table 1: Basic statistical properties of the main component of the PPI network and the HCC genes subnet. N is 
the total numbers of nodes. <k> is the average degree. e and <d> denote the efficiency and the average shortest 
distance between node pairs, respectively. <C> and r are the clustering coefficient and correlation coefficient 
of degrees, respectively. H is the degree heterogeneity, defined as <k
2
>/<k>
2
. 
Measures N <k> e <d> <C> r H 
Proteins (or genes) 9219 8.005 0.252 8.419 0.342 -0.036 4.411 
Disease genes 448 18.085 0.271 7.310 0.195 0.080 3.770 
Non-disease genes 8771 7.490 0.251 8.471 0.349 -0.053 4.173 
 
3. Methods 
3.1. Definition of the topological similarity  
3.1.1. Path-based Similarity (PS)  
The similarity between proteins (or genes) can be defined by using their essential attributes: two 
proteins are considered to be similar if they have the same or similar functions. However, available 
functional attributes are limited, and thus we focus on another type of similarity based on the PPI network 
topology. According to the used topological information, the topological similarity can be classified into 
two types: local similarity and global one[42-45]. Here, a set of path-based similarity indices, from local 
to global, are introduced.   
(1) Path-based Similarity of 1st order (PS1): To measure the topological similarity between two genes in 
the PPI network, many approaches have been developed. Among them, the simplest approach may be 
the path-based similarity of 1
st
 order, which is to assess whether two genes are connected directly in 
the network. If the two genes are directly connected by an edge, the similarity between them is 
defined as a constant of 1, otherwise zero. So, PS1 can be written as, 
1PS
xy xyS A ,                               (1) 
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where Axy is the matrix element of the adjacency matrix A: Axy=1 if nodes x and y are directly 
connected and Axy=0 otherwise. 
(2) Path-based Similarity of 2nd order (PS2): In common sense, nodes x and y are more likely to have 
similar properties if they have many common neighbors.
 
Hence, by combining PS1 with the 
common-neighbor feature, we can define the path-based similarity of 2
nd
 order as: 
 
2 2( )PSxy xy xyS A A  ,                          (2) 
where (A
2
)xy denotes the number of the common neighbors between nodes x and y, which is also the 
number of different paths with length 2. In addition,   is a free parameter of controlling the weights 
of paths with different lengths. 
(3) Path-based Similarity of 3rd order (PS3):  Above, PS2 has low computational complexity while they 
may still miss some useful information for underlying topological similarity, because they consider 
only the local paths with length 2. Therefore, we further consider paths with length 3, and define the 
path-based similarity of 3
rd
 order: 
    
3 2 2 3( ) ( )PSxy xy xy xyS A A A    ,                   (3) 
where (A
3
)xy denotes the number of different paths with length 3 between nodes x and y. In principle, 
one can further define the path-based similarity of higher order by considering the longer paths, while 
it may not be always necessary in general networks due to the small-word effect[39].
 
 
(4) Global Path-based Similarity (PSG): For comparison, we finally consider the global similarity which 
is based on all the paths between two nodes in the network, which can be written as: 
1
1
( )PSG n nxy xy
n
S A



  ,                         (4) 
where (A
n
)xy is equal to the number of paths of length n from node x to node y.  
In fact, PSG is equivalent to the Katz index that has been widely applied to characterize node 
similarity in complex networks[46]. In order to guarantee the convergence of PSG, the parameter   
must be smaller than the reciprocal of the maximum eigenvalue of the adjacency matrix A [43]. In this 
paper, we fixed  =0.01 for the three path-based similarities, PS2, PS3, and PSG. Of course, one can 
tune   to find optimal value corresponding to the highest prediction accuracy, however this optimal 
value is different for different similarity indices and one parameter-dependent measure is less practical in 
dealing with huge-size network since the tuning process may take much time. 
3.1.2. Community-based Similarity (CS) 
The PPI network shares many common properties with many other real-world networks, such as the 
small-world property, scale-free feature, and community structure [39]. Among them, community 
structure has been recognized as an important bridge to connect the topological structures and functional 
modules. It has been widely studied in various real-world networks such as the Internet,
 
the word wild 
web,
 
epidemiology,
 
metabolism,
 
ecosystems[33, 35, 39, 47, 48]. Here, we introduce the community 
structure into the disease-gene prediction problem, aiming to further improve the performance of the 
network-based disease-gene prediction. 
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Figure 1: The percentages of genes and disease genes in each community.  
 
Many methods have been recently developed to detect community structures in complex 
networks[49-51]. Here, the community structures in the PPI network are extracted by the BGLL 
method[52], because it has low computational complexity and high accuracy in community detection. The 
present PPI network is naturally divided into 25 communities and the corresponding modularity, which 
quantifies the modular property of the network, is equal to 0.533. And then we aggregate the genes and 
disease genes in each community and calculate their percentages with respect to the total candidate genes 
and the total disease-genes, respectively. The statistical results in these 25 communities are depicted in 
figure 1. One can find that the HCC disease-related genes should be functionally correlated and do not 
distributed randomly among the communities of the PPI network. For instance, about 77.7% of HCC 
disease-related genes are mainly distributed within 7 communities, and there are 8 communities without 
HCC disease-related gene. And more than 20% of disease genes are clustered in the 10
th
 community 
which has only 9% of genes in the whole network, while the 10
th
 community should include only 4.86% 
of the disease genes, if the disease genes are randomly distributed among the communities. 
The non-random distribution of disease-genes in communities might be very helpful for the 
disease-genes prediction. Institutively, in real-world networks, two individuals within the same 
community should be more similar than in different communities. For example, in the interpersonal 
relationship networks, community formation may be based on the human career, age and other factors;
 
in 
the metabolic network and neural network, communities may correspond to the functional units.
 
In order 
to extract the useful information in the community structure, we defined the community-based similarity 
as: 
0 , ;
0, ,
x yCS
xy
x y
S C C
S
C C

 

                              (5) 
where Cx is the label of the community to which node x belongs. We define S0=1/Nx, where Nx is the total 
number of genes in the community to which node x belongs. This means that the smaller the size of the 
community is, the more similar the genes in the community are. The reason of this consideration will be 
discussion in the following section about similarity score.  
3.1.3. Combined similarity based on path structure and community structure  
Based on path structures and community structure, a combined similarity of PS and CS (denoted by 
PS-CS) can be defined as: 
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(1 )PS CS PS CSxy xy xyS S S 
    ,                          (6) 
where [0,1]  is a free parameter to adjust the contribution of the paths and community structure to 
the similarity. If 0  , the community does not contribute to the similarity, i.e., the similarity indices 
will reduce to original PS. If 1  , it will be reduced to the CS.  
3.2. Similarity scores of genes with respect to the disease genes  
To prioritize the candidate disease genes, the similarity Score of a candidate gene x with respect to 
the disease gene set is calculated by summing the similarity of the candidate gene x with all known 
disease genes. For the path-based similarities, the similarity scores of candidate genes are written as: 
( , ) PSxy
y D
Score x PS S

  ,                           (7) 
where D denotes the disease genes set. For the community-based similarity, the score can be expressed as: 
( , ) CS xxy
y D x
n
Score x CS S
N
  ,                           (8) 
where nx denotes the number of disease genes in the community to which gene x belongs. In fact, nx/Nx is 
the abundance of the disease genes in the community. We employ it to reflect the degree of correlation 
between the community and the disease phenotype, i.e., if the abundance of the disease genes in a 
community is relatively high, this community may be considered to be closely related to the disease and 
the candidate genes in it will be more possibly related to the disease. 
According to the combined similarity of PS and CS, the similarity Score is then written as 
( , )
(1 )
(1 ) ( , ) ( , )
PS CS
xy
y D
PS CS
xy xy
y D y D
Score x PS CS S
S S
Score x PS Score x CS
 
 


 
  
   
    
.           (9) 
Finally, the candidate genes are sorted by the scores in decreasing order. The top predicted genes are more 
likely to be disease-related genes. 
3.3. Metric 
To estimate the performance of the prediction algorithms, the general process is that the known 
disease genes are randomly divided into several subsets. In each independent realization, one of these 
subsets is treated as test set, and remain subsets are put together to build a training set. And then we 
calculated the similarity score of every gene with respect to the genes in the training set. According to the 
scores, the genes will be sorted in decreasing order: The top genes are more likely related to the disease. 
We adopt two standard measures to determine the accuracy of disease-gene prediction methods: 
AUC (area under the receiver-operating characteristic curve) and precision. The AUC evaluates the 
performance based on the receiver-operating characteristic (ROC)
 
curve which can intuitively reflect the 
full-scale performance according the whole score list[53].
 
It is a two-dimensional graph in which 
true-positive rate is plotted on the Y axis and false-positive rate is plotted on the X axis. The true-positive 
rate (also called sensitivity or recall) and the false-positive rate (i.e., 1-specificity) is defined as 
TP
Ture positive rate Sensitivity
TP FN
 

,                   (10) 
and, 
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1
FP
False positive rate Specificity
FP TN
  

,                (11) 
where TP, FP, TN and FN represent true positive, false positive, true negative and false negative, 
respectively. By calculating the area under an ROC curve (i.e., AUC), one can obtain a single scalar value 
representing the comprehensive performance. Because AUC is a portion of the area of the unit square, its 
value will always be between 0 and 1. If AUC is smaller than 0.5, the prediction method will be 
completely ineffective. In a statistical sense, AUC could be considered as the probability that the score of 
a randomly chosen positive sample is higher than that of a randomly chosen negative sample. 
Different from AUC, precision only focuses on the top-L genes with highest scores. It is defined as 
the ratio of relevant items in the top-L list, i.e., the true-positive rate among selected top-L genes. That is 
to say, among the top-L genes, if Lr genes are accurately predicted, the precision is calculated by 
Pr r
L
ecision
L
 .                             (12) 
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Figure 2: The average topological similarity between genes by PS1, PS2, PS3, PSG and CS as a function of 
the percentage of disease genes in the substituted set. In order to avoid sampling bias, the random sampling is 
repeated 1000 times for each percentage of disease genes. Each point corresponds to the average of the 1000 
samples. 
4. Experimental results   
4.1. Analysis of feasibility 
In order to demonstrate the feasibility of our methods, we perform two different statistical analyses. 
On the one hand, we are to test whether the average level of the topological similarity (PS and CS) 
between disease genes is clearly different from that between non-disease genes as well as that between 
non-disease gene and disease gene. The average topological similarity between genes in the disease-gene 
set is calculated by 
, ,
(1 )
xy
x y D y x
D D
S
S
n n
 



,                             (13) 
where Sxy is referred to the similarity about PS1, PS2, PS3, PSG or CS. D and nD denote the disease-gene 
set and the number of disease genes in the disease-gene set, respectively. And then, we randomly select a 
certain percentage of disease genes from the disease-gene set D and replace them by the non-disease 
genes selected randomly from the non-disease gene set. This will generate a substituted disease-gene set 
that contains remaining disease genes and selected non-disease genes. According to equation (13), we 
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calculate the average similarity between genes in the substituted disease-gene set with different 
percentages of remaining disease genes, which is depicted in figure 2. In figure 2, it is clearly showed that 
the more the disease genes in the substituted disease-gene set, the higher the average similarity is. For 
example, when the percentage of the remaining disease genes is 100%, i.e., disease genes are not replaced 
by non-disease genes, the average similarities is significantly higher than those of all disease genes 
replaced by non-disease genes (i.e., the case of 0%). This indicates that the defined similarities above (PS 
and CS) should be able to effectively distinguish the disease genes from the candidate genes. 
On the other hand, the average similarity scores for all known disease genes and all candidate genes 
have been computed by using the path-based similarity (PS) and the community-based similarity (CS) 
(Table 2). Based on the definition of the similarity score, the average scores with respect to the disease 
gene set are calculated by  
( )
( )
y D
D
y
Score y
for disease genes
n
Score
Score y
for candidate genes
n







 



,                 (14) 
Where   and n denote the candidate gene set and the number of genes in the set, respectively. Table 2 
shows that, for each topological similarity, the average similarity score of disease genes is obviously 
higher than that of candidate genes. Therefore, one could expect that the prediction methods based on 
these similarities can help us to identify the disease genes from candidate genes. 
 
Table 2: The average similarity scores of disease genes and candidate genes with respect to the disease 
gene set, for different similarity definitions.  
Similarity Average Score (disease genes) Average Score (candidate genes) 
PS1 6.08×10
-3
 0.77×10
-3
 
PS2 8.29×10
-3
 1.20×10
-3
 
PS3 8.94×10
-3
 1.29×10
-3
 
PSG 9.32×10
-3
 1.47×10
-3
 
CS 6.19×10
-2
 4.80×10
-2
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Figure 3: The AUC values as a function of   for each PS-CS. 
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Figure 4: ROC curves from cross validations, by using different PS-CS with different α values, to predict 
HCC disease genes in the human PPI network. 
4.2. Performance of method 
4.2.1 ROC and AUC 
From the above statistical analysis, one can confirm that both the PS and CS are effective for 
predicting the disease genes. Naturally, it should be considered whether the combined similarity can give 
a better performance. Further, whether there exists the optimal the parameter   controlling the weights 
of PS and CS. In order to answer these questions, we calculate the AUC for different   (see figure 3). 
Interestingly, the prediction accuracy measured by AUC shows a maximum when 0.05  . Moreover, 
the optimal prediction accuracy is significantly higher than both those of single PS and CS. This indicates 
that better results are obtained by the combination of these similarities. In the following analysis, we 
focus on the three cases of 0.0  , 0.05   and 1.0  , corresponding to PS, the optimal 
combination of PS-CS as well as CS. The corresponding ROC curves and AUC values are showed in 
figure 4 and table 3. 
4.2.2. Precision 
To estimate the Precision of the methods, 50% of disease genes (224 genes) are randomly selected as 
training set, from the HCC disease-gene set. The remaining 224 disease genes mixing with a part of 
original non-disease genes are used as the probing set. Because the too large or too small sample sizes are 
not appropriate for statistical analysis, we randomly select 3076 non-disease genes in the PPI network. 
The prediction methods predict the disease genes from these 3300 (224+3076) candidate genes. The top 
L=165 genes (i.e., 5% of the candidate genes) are predicted as the disease genes. In order to avoid 
sampling bias, the random sampling above is repeated 1000 times and the results are showed in table 4. 
Similar to AUC, Table 4 shows that, by considering the community structure, the precision of the 
path-based similarity can be improved markedly. Without the community structure, the highest precision 
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is obtained by PS2, and the highest precision is also obtained by PS2-CS, after considering the 
community structure. Moreover, the maximum improvement of precision appears in PS3, from 0.263 to 
0.289, increasing by 10.0%, though AUC of PS3 (Table 2) is only increased by 4.6%. It means that after 
the addition of the community structure, the overall performance improvement (AUC of PS3) is not very 
obvious, but the quality of disease-gene prediction trends to move forward. Finally, in any case, it is clear 
that the community structure can be able to be helpful for the prediction of disease genes in the human 
PPI networks. 
 
Table 3: Prediction accuracies measured by AUC. 
Similarity 
AUC 
0.00   0.05   1.00   
PS1-CS 0.703 0.748 0.657 
PS2-CS 0.724 0.754 0.657 
PS3-CS 0.720 0.753 0.657 
PSG-CS 0.719 0.752 0.657 
 
 
Table 4: Prediction accuracies measured by Precision. 
Similarity 
Precision 
0.00   0.05   1.00   
PS1-CS 0.258 0.280 0.178 
PS2-CS 0.266 0.291 0.178 
PS3-CS 0.263 0.289 0.178 
PSG-CS 0.262 0.286 0.178 
 
4.2.3. Discussion 
From Table 3 and 4, we can find that the performance of prediction algorithm based on PS is 
significantly better than that for CS. According to the definition of CS, the similarity between genes 
within the same community is the same, which will cause that a large number of gene pairs are assigned 
identical similarity. If we regard the similarity as the energy that is assigned to the gene pairs, then many 
gene pairs crowed into very few energy levels. Taking the present detected communities as an example, 
there are at most 25 energy levels, since the PPI network are divided into 25 communities. Therefore, the 
performance of the CS method is possibly rooted in the high degeneracy of the energy status. However, 
the PS could break the degeneracy, and give the relative good performances. Among the four PS methods, 
the highest AUC value has been obtained by PS2, and the lowest one is given by PS1. Although PS1 
requires only information on the nearest neighbors and thus has very low computational complexity, 
while the information generally seems to be insufficient. On the other hand, the PSG has the highest 
computational complexity, but its prediction accuracy is not beyond those of PS2 and PS3. Perhaps, 
because the PPI network shows strong small-world effect, considering the 2-order or 3-order local paths 
for the disease-gene prediction seems to be enough. This situation is very similar to the link prediction 
based on the local path similarity index, where it is also confirmed that the global path-based similarity is 
not always necessary for some real networks with strong small-world effect[54]. 
When comparing the AUC and Precision of the combined similarity ( 0.05  ) with that of PS 
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( 0.0  ) and CS ( 1.0  ), a great improvement can be obtained due to the combination of PS and CS. 
The excellent performance of the methods may result from that the non-random distribution of disease 
genes in communities can provide very useful information for the prediction of the disease-gene family. 
On the one hand, the genes in the same community often have higher similarity than between 
communities, and especially, the similarity scores of the candidate genes with respect to the disease gene 
set, by the definition of CS, exactly corresponds to the abundance of disease genes in the communities. 
Generally, if the known disease genes related to the certain disease are very scarce or even absent in a 
community, the possibility of the candidate genes in this community being the disease genes may be very 
low; vice versa, if the relative number of disease genes is very large in a community, the candidate genes 
in this community are more possible to be related to the disease. Therefore the information of community 
structure could be helpful for the identification of the disease genes in the PPI network.  
Theoretically, the combination of different similarities may be particularly relevant for disease gene 
prediction, if they are designed independently by different methods. In our case, the PS and CS were 
designed to assess the similarity of genes in PPI network from different while related sides. In fact, there 
exists correlation between PS and CS. For example, the similarity indices such as PS can be applied to 
community detection, where the node pairs with high similarity are generally clumped into 
communities[42]. However, the two similarities should not be correlated strongly too, otherwise they will 
generate the same or similar results in the disease-gene prediction. In our previous work[55], a 
network-based prediction method has been developed by using the global path-based topological 
similarity and confirmed that path-based similarity could give a relatively good performance for disease 
genes prediction. In present work, the CS has been introduced as a novel feature to assess modularity of 
proteins in the PPI network. The introduction of the CS further enhanced the prediction performance, 
which indicates that the community structure may reflect some features of disease genes in the PPI 
networks. The information from PS and CS could complement each other, and thus the combination can 
finally lead to better performance for predicting disease genes in the human PPI network.   
5. Conclusion 
In this paper, in order to predict disease genes in the human PPI network, a set of path-based 
similarity methods and community-based similarity methods were introduced, and then a kind of 
combined similarity methods was proposed by considering the path structure and community structure in 
the networks. We analyzed the feasibility of the similarity methods for predicting the disease genes in the 
PPI network, and investigated the effect of the community structure on the prediction of the disease genes. 
The results indicated that the performance of the prediction methods can be greatly improved due to the 
introduction of the community structure, though the alone community-based similarity method is not 
good at predicting the disease genes in the PPI networks.  
In general, proteins seldom function independently, while rather in a modular fashion. When 
combining the path-based similarity with the community-based similarity, the prediction performance not 
only improves, but the advantage of the low computational complexity of the methods (such as PS1, PS2 
and PS3) also preserves. From the above results, one could validate that the community structure is a 
significant feature for improving the performance of disease-gene prediction. The genes related to the 
disease may be indeed clustered into modules in the PPI network. Thus, exploring the modular feature of 
proteins in the PPI network would be considerably important for both developing effective disease-gene 
prediction methods and understanding the underlying functions of proteins. 
Moreover, we also have noted that the disease genes may be situated at the border of communities, 
while not inside, which may also be helpful for the prediction of disease genes. In the future, the 
Manuscript                                                          Thursday, July 20, 2017 
 13 
 
distribution of disease genes in communities should be deserved to further study in predicting disease 
genes. Finally, we believe that community structure, as a relevant and intuitional feature for 
characterization of networks, should be able to easily combine with other methods so as to predict disease 
genes more effectively.   
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